A large scale virtual screen of DprE1.

Area of Science:

• Medicinal Chemistry
• Computational Drug Discovery
• Infectious Diseases

Background:

• Tuberculosis (TB) remains a global health challenge, with increasing drug-resistant strains (MDR and XDR) necessitating novel therapeutic strategies.
• The World Health Organization estimates one-third of the global population is infected with TB.
• Identifying new drug targets is crucial for combating TB.

Purpose of the Study:

• To conduct a large-scale virtual screening of chemical compounds to identify potential drug leads for tuberculosis.
• To evaluate the efficacy of compounds against the DrpE1 drug target, a promising target for novel TB therapeutics.

Main Methods:

• A virtual screening of 4.1 million compounds was performed.
• Compounds were sourced from the Zinc database.
• Molecular docking simulations were executed using AutoDock Vina to assess binding affinity against the DrpE1 target.

Main Results:

• The virtual screening successfully identified several compounds with high potential for therapeutic development.
• Computational analysis revealed promising interactions between screened compounds and the DrpE1 target.

Conclusions:

• This study demonstrates the utility of virtual screening in identifying novel drug candidates for tuberculosis.
• The identified lead compounds represent a promising starting point for the development of new anti-TB drugs to combat resistant strains.